Introduction and hypothesis The unexpected absence of urodynamic stress incontinence (USI) in women planning surgery for stress urinary incontinence (SUI) is a challenge to surgeons. We examined the prevalence and clinical and demographic factors associated at baseline (preoperatively) with the unexpected absence of USI among study participants of two multicenter randomized clinical trials of surgery for treating SUI. Methods Women with SUI symptoms and positive stress tests on physical examination enrolled in two separate clinical trials-one comparing the autologous fascial sling with the Burch colposuspension [Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr), and the other comparing the retropubic mid-urethral sling with the transobturator midurethral sling [Trial of Mid-Urethral Slings (TOMUS)]-were evaluated for USI preoperatively. The association of clinical, demographic, and urodynamic parameters was examined in women without USI in univariate and multivariate analyses. Results Overall, 144 of 1,233 women (11.7 %) enrolled in the two studies showed no USI. These women had a significantly lower mean volume at maximum cystometric capacity than those with USI (347.5 vs. 395.8 in SISTEr, p00.012), (315.2 vs. 358.2 in TOMUS, p00.003) and a lower mean number of daily accidents reported on a 3-day diary (2.2 vs 2.7 in SISTEr, p00.030) (1.7 vs 2.7 in TOMUS, p<0.001). Additionally, those without demonstrable USI were more likely to have Pelvic Organ Prolapse Quantification (POP-Q) stage III/IV (31.7 % vs 14.4 % in SISTEr, p00.002), (15.5 % vs 6.9 % in TOMUS, p00.025). SUI severity as recorded on the Urogenital Distress Inventory (UDI) correlated strongly with the presence of USI in both studies. Conclusions We observed that about one of eight women planning surgery for SUI does not show USI. Stage 3/4 POP was strongly associated with the unexpected absence of USI. A diminished urodynamic bladder capacity among women who did not display USI may reflect an inability to reach the limits of capacity during urodynamics, at which these women normally leak.
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Introduction
Stress urinary incontinence (SUI) is among the most common forms of urinary incontinence reported by women. Distinguishing the type of urinary incontinence is often difficult, with physical exam, questionnaires, and urodynamic studies often being used, either individually or combined, to evaluate and categorize the type of leakage. Relying solely on patient history or urinary incontinence questionnaires may lead to an inappropriate diagnosis in certain women [1] , whereas establishing the presence of urodynamic stress incontinence (USI) may be considered overuse of an invasive and costly diagnostic tool, with questionable reproducibility [2] .
USI has been proposed as the gold standard for diagnosing stress incontinence in women. However, some women with bothersome symptoms of SUI may not display USI. We previously observed that approximately 10 % of women enrolled in a randomized clinical trial of Burch colposuspension versus fascial slings had an unexpected absence of a urodynamic finding of USI, despite reporting pure or predominant symptoms of SUI and having a positive standardized urinary stress test during pelvic exam [3] . There are several possible reasons why USI may not be observed in women with symptoms and/or physical exam evidence of SUI. Pelvic floor muscle tone induced by the actual test procedure, partial occlusion of the urethra by the physical presence of a catheter, an inability to recreate the precise inciting event for SUI, and coexisting pelvic organ prolapse (POP) have all been suggested as possible reasons for failing to elicit USI in women reporting SUI [4] . The inability to demonstrate USI in a woman considering surgery for SUI poses a challenge in confirming the correct diagnosis and recommending appropriate treatment.
The clinical significance of failing to observe USI among women with diagnosed SUI is uncertain. The presence of USI is associated with improved overall surgical success in the case of pubovaginal sling and Burch colposuspension, but, interestingly, lower objective success for midurethral slings. Less is known about the clinical and demographic findings in patients not found to have USI. Whether this finding is associated with altered SUI severity, as reported by questionnaire, or other characteristics of women reporting SUI requires study. Furthermore, a better understanding of the characteristics of women with SUI who do not demonstrate USI may provide insight into the mechanism(s) of stress leakage as well as identifying women who should undergo urodynamic testing. We report this secondary analysis on a broad range of clinical and demographic characteristics and urodynamic study findings in women with SUI enrolled in two randomized clinical trials of surgery who had an unexpected absence of USI.
Materials and methods
This secondary analysis of women enrolled in two randomized clinical trials includes those randomized in the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr) and the Trial of Mid-Urethral Slings (TOMUS). SISTEr compared the autologous fascial sling with the Burch colposuspension. TOMUS compared retropubic and transobturator midurethral slings [5] . Information obtained and tests performed at baseline (preoperatively) included age, weight, height, body mass index (BMI), concomitant surgery, Q-tip test, POP Quantification (POP-Q), pelvic muscle strength (Brinks score), full bladder and supine empty bladder stress test, 24-h pad weight test, and 3 day voiding diary to measure incontinence episodes and symptoms. Selfreported measures included the Urogenital Distress Inventory (UDI), the Medical, Epidemiological, and Social Aspects of Aging Questionnaire (MESA) with stress and urge subscales, the Incontinence Impact Questionnaire (IIQ), and a question regarding expectation about upcoming surgery. To qualify for inclusion in the trials, all patients had to leak during a supine stress test (bladder volumes 200-300ml). Patients went on to surgery, regardless of the presence of USI.
Urodynamics
Standardized urodynamic testing, including noninvasive uroflow (NIF), filling cystometry in the standing position, and pressure-flow studies (PFS), were performed on all women prior to surgery in both studies. Urethral pressure profilometry (UPP) was performed in TOMUS but not in SISTEr. To evaluate USI, Valsalva leak point pressures (VLPP) were measured during filling beginning at a volume of 200 cc and then again in 100-cc increments until leakage was demonstrated or capacity was reached. If the patient had reached capacity and had not leaked with Valsalva, a cough test was performed. SISTEr patients with stage ≥3 prolapse had VLPP testing done with and without prolapse reduction during filling and at maximum cystometric capacity (MCC).
In TOMUS, prolapse reduction testing was not performed. Presence or absence of USI was defined as at least one episode of SUI with a cough or a Valsalva maneuver at any point during filling with or without prolapse reduction. Detrusor overactivity and detrusor overactivity incontinence were recorded if present. MCC was defined as the instilled volume at which the patient had a strong urge to urinate and could accommodate no more fluid. Maximal flow (Q max ) and detrusor pressure at Q max (P det @ Q max ) were also recorded from the PFS.
Statistical analysis
Descriptive statistics were calculated for each study by USI status to assess differences between patients. T tests were used to compare means and Wilcoxon rank sum tests to compare medians for variables that were skewed (e.g., pad weights, accidents/day, volume at MCC). To investigate which covariates were most likely to independently predict not having USI, multivariable logistic regression models were fit using a two-stage process: First, we fit a preliminary multivariable model that included all variables reaching the 0.05 level of significance from separate bivariate models as well as clinically significant variables. Second, based on the preliminary multivariable model, variables that did not reach the 0.05 level of significance were deleted to form a final model for SISTEr. The same model-building technique was repeated for TOMUS. Additional model fitting was done to ascertain whether similar variables could be included in the final models for the two trials. Akaike's information criteria (AIC) was used to assess model fit and for model comparison [6] . Results are presented as odds ratios (OR), with corresponding 95 % confidence intervals (CI), to predict women not having USI. Analyses were performed with SAS statistical software, version 9.2 (SAS Institute). This study was submitted and approved by the institutional ethics committee of all nine participating sites.
Results
The rates of preoperative USI in both trials were 91 % and 86 %, respectively. Table 1 shows study variables for each clinical trial and the demonstration (or not) of USI. In both studies, women who did not show USI had a significantly lower mean volume at MCC (p00.012, p00.003 for SISTEr and TOMUS, respectively) and a lower mean number of daily accidents reported on a 3-day diary compared with women who displayed USI (p00.030, p<0.001). Women without USI had significantly lower mean UDI stress scores in both studies (p00.013, p00.004), higher UDI obstructive scores (p00.041, p00.042) ,and were about twice as likely to have POP-Q stage III/IV (p00.002, p00.025). Patients with POP-Q stage III/IV in SISTEr had prolapse reduction during UDS and 18.4 % (19/103) had no USI, whereas in TOMUS (when prolapse reduction was not performed), patients with POP-Q stage III/IV had a 27.1 % (13/48) rate of no USI (p00.23).
In TOMUS, women in the no-USI group had significantly lower mean total (p<0.001), stress (p<0.001), and urge ME-SA scores (p00.030). In contrast, women enrolled in TOMUS who did not show USI were more likely to have a significantly higher mean P det @ Q max (p00.001) and to undergo concomitant surgery (p<0.001). Based on our findings, multivariate logistic regression models were created to predict absence of preoperative USI for each study. For example, for SISTEr, the following variables were considered: UDI stress score, UDI obstructive score, number of incontinence episodes per day from a 3-day voiding diary, volume at MCC, baseline POP-Q stage, and P det @ Q max . Variables no longer significant in the multivariate analysis were removed, and results of the final model are shown in Table 2 . Lower UDI stress scores and lower volume at MCC were related to the odds of a woman not having USI. For every 10-U increase in UDI stress score, the odds of having no USI decreased by 12 % (OR with 95 % CI 0.88, 0.78-0.99; p00.028). Considering volume at MCC, for every 50-ml increase, the odds of no USI decreases by 15 % (OR 0.85, 0.76-0.96; p00.009). Women with baseline POP-Q stage III or IV were more than twice as likely to not display USI than patients with stage 0 or I (OR 2.65, 1.14-6.16); p00.035).
For TOMUS the following variables were considered: P det @ Q max , MESA stress and urge scores, UDI stress and obstructive scores, number of accidents per day by diary, volume at MCC, baseline POP-Q stage, and concomitant surgery. The results of the model are shown in Table 2 . Higher P det @ Q max was positively related to no USI, whereas the number of incontinence episodes per day and MCC volume were inversely related to no USI. Specifically, as P det @ Q max increases, the odds of no USI also increases; (OR 1.03, 1.01-1.06; p00.004). Regarding the number of incontinence episodes per day by diary, for every 1-U increase in incontinence episodes/day, the odds of no USI decreases by >25 % (OR 0.71 0.59-0.86; p<0.001). For volume at MCC, with every 50-ml increase, the odds of no USI decreases by >20 % (OR 0.79 0.67-0.93; p00.004).
To investigate similarities between SISTEr and TOMUS, we created multivariate models for both studies using the same variables, including UDI stress score, volume at MCC, POP-Q stage, P det @ Q max , and episodes per day. Results of this comparison confirm that the two trials were quite similar in regards to relationships of assessed variables with the odds of no USI (not presented). Whereas each relationship did not necessarily reach statistical significance, UDI stress score, volume at MCC, and average number of incontinence episodes per day were associated with lower odds of no USI, whereas higher POP-Q stage and P det @ Q max were associated with higher odds of no USI.
Discussion
This secondary analysis of women enrolled in two clinical trials of surgery for symptomatic SUI provides a unique opportunity to examine how women with symptoms and demonstrable SUI in the office but without USI may differ from those with USI. These women were more likely to have less SUI symptoms, more obstructive voiding symptoms, fewer daily incontinence episodes, higher-stage prolapse, higher P det @ Q max , and a lower MCC than women with USI.
We found that more pronounced prolapse was about twice as common in women who did not display USI than those who did. Prolapse can produce urethral kinking and obstruction, which poses a challenge for urodynamic testing, and the optimal method for prolapse reduction is not known [7] . This effect may be compounded by the presence of a urethral catheter [8] . Prolapse reduction is commonly performed during urodynamic testing, and our study does suggest that without prolapse reduction, the diagnosis of no USI may be more likely. We found a lower rate of no USI (18.4 %) in our SISTEr patients with advanced prolapse when prolapse reduction was performed during UDS than we did in comparable TOMUS patients when no prolapse reduction was performed during UDS (27.1 %), although this difference was not statistically significant. It may be that prolapse reduction during UDS is more important during urodynamics in patients without symptoms of SUI: prior studies document that only 4 % of women with prolapse and without SUI symptoms demonstrate USI without prolapse reduction, even though 27 % demonstrate it with prolapse reduction [9] . Prolapse and its related urethral obstruction are the likely reason these women had a higher P det @ Q max and may explain why they had fewer daily incontinence episodes. The finding that women without USI had a lower MCC is interesting. It is well known that in any given individual with SUI, SUI is more common at higher bladder volumes, and the odds of eliciting it are increased at higher volumes. We may not have elicited USI because, despite the standardized approach to measure MCC, we may not have "pushed" the patients to a high enough volume to elicit USI. It is also possible that the act of artificial filling during urodynamics alters the sensory threshold, such that the normal volume at which women leak is not reached-another potential artifact of urodynamic testing. These findings emphasize the possible importance of reaching full MCC to increase sensitivity of USI detection.
The strengths of our study include detailed characterization of a very large population (144 women) with symptoms and signs of SUI without USI. A potential limitation of our study is that we conclude that advanced prolapse poses a twofold risk for not demonstrating USI, though prolapse reduction maneuvers were performed only in the SISTEr study. We believe this does not affect our conclusion because: (1) there were very few (13) participants in TOMUS with advanced prolapse who had no USI (and thus reducing them would have uncovered very few, if any, cases of USI); and (2) rates of no USI for this TOMUS group were not significantly different than those overall in SISTEr (including those reduced and nonreduced).
Overall, our findings may be reassuring for clinicians who recommend SUI surgery based on history and physical and office testing demonstrating SUI, despite the unexpected absence of USI. Women who meet our study criteria for SUI surgery despite a lack of urodynamic evidence for USI appear to have similar surgical outcomes. In SIS-TER, women without USI had a tendency for higher failure rates [10] ; in TOMUS, women without USI had a tendency for lower failure rates [11] , suggesting that the impact using contemporary treatments for SUI (MUS) might be negligible. Indeed, recent guidelines suggest that patients with demonstrable SUI and minimal voiding dysfunction or urgency symptoms may proceed to surgery without urodynamics [12] , though clearly characterizing the group of patients who might be best served by preoperative urodynamics requires further clarification.
Conclusions
In conclusion, we found that women with SUI symptoms and demonstrable office SUI but without USI are more likely than their counterparts with USI to have more obstructive symptoms, fewer incontinence episodes, more prolapse, higher voiding pressures, and lower bladder capacities. Our previous results do not suggest that they have worse surgical outcomes after midurethral sling. An ongoing multicenter trial will further evaluate the utility of routine use of urodynamics prior to SUI surgery [13] .
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